Dexcom (DXCM) Return on Equity [ROE] (2011 - 2026)
Dexcom's Return on Equity [ROE] was 35.84% in Q2 2026, up 12.23 percentage points from 23.62% a year earlier and up 3.21 percentage points from the prior quarter.
Powered by 
Analysis
Dexcom (DXCM) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Dexcom came in at 34.50%, up 6.87 percentage points from FY2024.
- Return on Equity [ROE] has now increased for four consecutive years, though with a five-year change of -10.66 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was 27.63% in FY2024 (+1.84 pp), 25.78% in FY2023 (+9.43 pp), 16.35% in FY2022 (+4.28 pp) and 12.07% in FY2021 (-33.09 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q2 2021.
- Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of +3.24 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 18.35 percentage points); the worst was Q2 2022 (a drop of 26.02 percentage points).
- Per Business Quant data, DXCM's Return on Equity [ROE] in the three quarters before Q2 2026 was 32.63% (Q1 2026), 30.57% (Q4 2025) and 27.20% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 13.36% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 10.39% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 7.56% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 17.60% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 10.44% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | -3.90% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 14.31% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 9.53% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 3.88% |
| 10 | Dexcom | 32.57 Bn | 22.88 Bn | 830.00 Mn | 35.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.84% |
| Mar 31, 2026 | 32.63% |
| Dec 31, 2025 | 30.57% |
| Sep 30, 2025 | 27.20% |
| Jun 30, 2025 | 23.62% |
| Mar 31, 2025 | 24.50% |
| Dec 31, 2024 | 28.23% |
| Sep 30, 2024 | 30.85% |
| Jun 30, 2024 | 28.49% |
| Mar 31, 2024 | 29.63% |
| Dec 31, 2023 | 24.97% |
| Sep 30, 2023 | 17.26% |
| Jun 30, 2023 | 16.50% |
| Mar 31, 2023 | 13.40% |
| Dec 31, 2022 | 17.25% |
| Sep 30, 2022 | 11.96% |
| Jun 30, 2022 | 10.36% |
| Mar 31, 2022 | 12.18% |
| Dec 31, 2021 | 10.97% |
| Sep 30, 2021 | 34.55% |
API Access
Dexcom Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DXCM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "DXCM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DXCM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();